Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials?
Publication
, Journal Article
Voora, D
Published in: Per Med
January 2013
Duke Scholars
Published In
Per Med
DOI
EISSN
1744-828X
Publication Date
January 2013
Volume
10
Issue
1
Start / End Page
1 / 3
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Voora, D. (2013). Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials? Per Med, 10(1), 1–3. https://doi.org/10.2217/pme.12.105
Voora, Deepak. “Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials?” Per Med 10, no. 1 (January 2013): 1–3. https://doi.org/10.2217/pme.12.105.
Voora D. Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials? Per Med. 2013 Jan;10(1):1–3.
Voora, Deepak. “Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials?” Per Med, vol. 10, no. 1, Jan. 2013, pp. 1–3. Pubmed, doi:10.2217/pme.12.105.
Voora D. Building the evidentiary framework for pharmacogenetic testing: is it time to move beyond randomized controlled trials? Per Med. 2013 Jan;10(1):1–3.
Published In
Per Med
DOI
EISSN
1744-828X
Publication Date
January 2013
Volume
10
Issue
1
Start / End Page
1 / 3
Location
England
Related Subject Headings
- Pharmacology & Pharmacy
- 3214 Pharmacology and pharmaceutical sciences
- 3202 Clinical sciences